News
A study describes a new way to generate insulin-producing cells
Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.
The “Ellas contra la ELA” campaign ends with more than 13.500 euros raised
Today, June 21, World ALS Day, the campaign “Ellas contra la ELA” ends, a women’s football solidarity competition for ALS research.
A neuroscientific study in the Sónar+D shows that we remember better and are predisposed to pay more for songs that arouse our curiosity
Through a live experiment, researchers assessed the curiosity aroused by a new song and its impact on audience memory and decision-making.
The second round of STARS escape room implementations has been a success
One and a half year after its debut, the STARS Game project has just reached its midpoint, Thus, the four partners have already delivered two rounds of workshops and implementations. Everyone’s experience regarding the escape room ended up being very positive and rewarding.
Ernest Nadal presents at ASCO the benefits of treating patients with lung cancer and brain metastases with chemo-immunotherapy
A group from IDIBELL, Catalan Institute of Oncology, and the Spanish Lung Cancer Group (GECP) have shown that the combination of atezolizumab with carboplatin and pemetrexed is safe and effective as a first treatment option in a group of 40 patients.
Large-scale genotyping identifies the molecular cause of two cases of familial globozoospermia
A genome-wide association study in a family with two males with infertility due to globozoospermia allows the identification of the first case of compound heterozygosis for two different mutations in the DPY19L2 gene.
A new international guideline helps advance in diagnosis and treatment of progressive pulmonary fibrosis
A new international consensus guideline based on scientific evidence represents an improvement in the diagnosis and treatment of patients with certain fibrosing lung diseases.
A new treatment is effective for advanced HER2-low breast cancer
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and overall survival compared with the usual treatments.
Researchers discover a set of poor prognosis markers in patients with colon and rectal cancer
This is a group of genes that are expressed in cancer cells that survive chemotherapy treatment. Its activity generates resistance to treatment and a greater capacity to cause metastasis.